Teva®, a division of Deckers Brands (NYSE: DECK), announces the arrival of its spring-summer 2025 collection and new anthem ...

The shoe brand has launched “For Playground Earth,” a new anthem and collection created to “push people to play outside." ...

Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Hill House’s latest capsule expands on its existing silhouettes, offering new nap dress colorways and adding details like ...

NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the ...

Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents ...

A federal court has signed off on a $700 million class action settlement that will see drug manufacturers and distributors ...

New York, New York-- (Newsfile Corp. - March 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Trade Desk, Inc. (NASDAQ: TTD) and ...